Molecular dissection of mouse soluble guanylyl cyclase α1 promoter

被引:13
|
作者
Vazquez-Padron, RI [1 ]
Pham, SM
Pang, MH
Li, S
Aïtouche, A
机构
[1] Miami Univ, Dept Surg, Miami, FL USA
[2] Miami Univ, Vasc Biol Inst, Miami, FL USA
关键词
soluble guanylyl cyclase; promoter; dinucleotide microsatellites; transcriptional regulation; UTR regions;
D O I
10.1016/j.bbrc.2003.12.078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Soluble guanylyl cyclase (sGC) is the only known receptor for nitric oxide (NO) and is downregulated in aging and hypertension. Little is known about sGC gene transcriptional regulation. In order to characterize the sGC transcriptional system, we cloned and sequenced the 5' flanking region of mouse sGC a(1) gene (AY116663). Structurally, it is a non-canonical TATA-less promoter that we mapped to chromosome 3 with many putative regulation sites for Sp-1, NF-kappaB, and AP-1 transcription factors amongst others, and two (TG:CA)(n) dinucleotide microsatellites near the transcriptional start point. The cloned upstream sequence produced a 5-fold increase in luciferase activity in Cos7, HeLa, NIH3T3, and 293 cells as well as in mouse VSMC-like kidney mesangial cells. In the latter cell type, we showed that sGC alpha(1) promoter activity was dependent on the presence of its 5' unstranslated region (5'UTR). (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:208 / 214
页数:7
相关论文
共 50 条
  • [21] Localization of soluble guanylyl cyclase α-subunit in identified insect neurons
    Elphick, MR
    Jones, IW
    BRAIN RESEARCH, 1998, 800 (01) : 174 - 179
  • [22] Androgen regulation of soluble guanylyl cyclaseα1 mediates prostate cancer cell proliferation
    Cai, C.
    Chen, S-Y
    Zheng, Z.
    Omwancha, J.
    Lin, M-F
    Balk, S. P.
    Shemshedini, L.
    ONCOGENE, 2007, 26 (11) : 1606 - 1615
  • [23] Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase
    Olesen, SP
    Drejer, J
    Axelsson, O
    Moldt, P
    Bang, L
    Nielsen-Kudsk, JE
    Busse, R
    Mülsch, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (02) : 299 - 309
  • [24] Biased activity of soluble guanylyl cyclase: the Janus face of thymoquinone
    Charlotte Detremmerie
    Paul M. Vanhoutte
    Susan Leung
    ActaPharmaceuticaSinicaB, 2017, 7 (04) : 401 - 408
  • [25] Toward structural insights into activation and modulation of the soluble guanylyl cyclase
    Kumar, Vijay
    Stamler, Jonathan
    Stasch, Johannes-Peter
    Hahn, Michael
    Schaefer, Martina
    Giannis, Athanassios
    Papapetropoulos, Andreas
    van den Akker, Focco
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2014, 42 : 112 - 112
  • [26] The Role of Soluble Guanylyl Cyclase in Chronic Obstructive Pulmonary Disease
    Glynos, Constantinos
    Dupont, Lisa L.
    Vassilakopoulos, Theodoros
    Papapetropoulos, Andreas
    Brouckaert, Peter
    Giannis, Athanassios
    Joos, Guy F.
    Bracke, Ken R.
    Brusselle, Guy G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (07) : 789 - 799
  • [27] Disruption of retinogeniculate pattern formation by inhibition of soluble guanylyl cyclase
    Leamey, CA
    Ho-Pao, CL
    Sur, M
    JOURNAL OF NEUROSCIENCE, 2001, 21 (11) : 3871 - 3880
  • [28] The deactivation of soluble guanylyl cyclase by redox-active agents
    Dierks, EA
    Burstyn, JN
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 351 (01) : 1 - 7
  • [29] Role of soluble guanylyl cyclase in renal afferent and efferent arterioles
    Wennysia, I. C.
    Zhao, L.
    Schomber, T.
    Braun, D.
    Golz, S.
    Summer, H.
    Benardeau, A.
    Lai, E. Y.
    Lichtenberger, F-B
    Schubert, R.
    Persson, P. B.
    Xu, M. Z.
    Patzak, A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 320 (02) : F193 - F202
  • [30] Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species
    Gerassimou, C.
    Kotanidou, A.
    Zhou, Z.
    Simoes, D. C. M.
    Roussos, C.
    Papapetropoulos, A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (08) : 1084 - 1091